Our portfolio companies

Summary

AMW is an innovative specialty-pharmaceutical company. It develops and manufactures active and passive transdermal patches, biodegradable subcutaneous implants, and intravaginal rings, by using its patented and proprietary technologies. Key-activities are innovative products and applications for indications such as oncology, neurology, ophthalmology, endocrinology, diabetes and pain treatment.

Summary

AOT is a Swiss MedTech company developing surgical solutions by integrating optics, robotics and digital technologies. The company’s vision is to significantly improve outcomes of osteotomies by offering digital surgical solutions. Thus, the company has developed CARLO®, the world’s first contact-free laser osteotome which allows to overcome the limitations of interventional mechanical instruments used today. The company’s solutions shall improve patient recovery times, reduce complication rates and lower overall procedure costs.

Summary

Betterguards Technology develops and produces "safety belts" for human joints. The technology offers intelligent protection and only activates in case of critical movements. During normal activities, however, the system is flexible and guarantees a natural freedom of motion. This combination is unique on the market and, in addition to the protective effect, is primarily intended to offer people more freedom, comfort and courage during their movements. The Betterguards system can be integrated as a component into i.e. supports, orthoses, and shoes.

Summary

Blazejewski MEDI-TECH (BMT) develops best-in-class rigid and semi-rigid 2D- and highly innovative 3D-endoscopy systems with a very small diameter along with a high class resolution. The products are marketed with partners, applications are mainly in neurology, spine, ENT, urology and gynaecology. The 3D-visualisation systems are also applied in robotics.

Summary

Blue Ocean Spine is developing functional and 3D printed interbody fusion cages. These spine implants are placed between vertebral bodies which consequently grow together and finally result in restabilizing a patient’s spine. Blue Ocean Spine’s next generation of cages enable quicker and safer surgeries while patient specific requirements can be addressed.

Summary

Transcatheter mitral valve repair system. Replaces defective Chordae Tendineae (threads) in a minimal-invasive procedure.

Summary

Develco Pharma is a specialty pharmaceutical company that develops and produces innovative formulations for drugs with known active ingredients. After approval, the products are licensed out to internationally operating pharmaceutical companies. Develco Pharma is responsible for the entire value chain from development and approval to manufacture and delivery. By focusing on extended or modified releases, the company has grown into an internationally recognized and renowned provider.

Summary

Dr.Dropin’s digi-physical approach consists of leveraging physical clinics with digital offerings. The company’s target is to provide the patient with a “one-stop shop” and thereby simplify the service offering. This includes: Primary care and other health related services (gynaecology, dermatology, physical therapy, pediatrics, psychology), physical and video consultations, lean staffing model, short waiting times (15 min for digital consultation, same day for physical consultation).

Summary

The company develops and markets software solutions for education/training, process digitization and process optimization concerning operation rooms (OR) in hospitals. In doing so the company helps making surgeries more efficient and less error-prone. Patients and hospitals will profit from this alike. Currently, the company has more than 200 hospital clients in over 18 countries. The education/training is already on the market.

Summary

Lowenco develops, produces and sells Ultra-Low Temperature (ULT) storage solutions for pharma and biotech customers. The company is already a preferred supplier to several of the largest Biotech and Pharma companies worldwide and is, based on it`s unique value proposition to it`s customers, very well positioned to continue addressing the increasing demand for ULT storage solutions, which is driven by the strong underlying growth in biopharma volumes.

Summary

Miracor's “PICSO” therapy is aiming to significantly reduce the damage to the heart muscle after an heart attack. Clinical studies ongoing. CE Mark of next-generation system obtained in Q2 2020.

Summary

Company with globally-leading devices for the diagnostics of pulmonary function. ndd’s EasyOne® is market-leader in spirometry, ndd’s EasyOne Pro® enables PoC testing of the important pulmonary and cardio-pulmonary markers. ndd’s products are chosen for many and highly-regarded clinical trials (e.g. COPD Gene), including clinical trials of the pharmaceutical industry.

Summary

Software-solutions for the automatized recognition and categorization of epileptic seizures. Neuro Event Labs enables neurologists to make more detailed diagnoses and to individually adjust therapies to each patient’s needs. The company makes it possible to observe patients both in clinics and at home. Further neurological indications are in the pipeline.

Summary

Production and sales of medical aids like fixations and pads for the intensive care, anaesthetic and nursing sectors especially:

• Trancheostomy/laryngectomy – fixations and supply
• Breathing support – fixations, ventilation tubes and supply
• Safety systems and prophylaxis

Summary

numares is about to disrupt the lab diagnostics market. The company’s technology utilizes physics (NMR) and software (AI) to enable better understanding of organ functions. Instead of single biomarkers, numares’ software platform evaluates biomarker sets – metabolite constellations – in hundreds of analysed metabolites, showing not only the function of a single organ but also the influence of a diseased organ in the interaction with the organ system.

Summary

PathoQuest offers advanced Next Generation Sequencing (NGS) solutions in biosafety testing that supplement or replace traditional testing methods and support the strategic decision-making process for the release of biological products like vaccines, cell & gene therapies, Ab-based biologics, etc. The company has a direct presence in Europe as well as in the US market.

Summary

The company is developing an intramedullary limb lengthening nail to treat leg length discrepancies or to address non-unions after failed fracture treatments or tumors. Intramedullary limb lengthening devices still represent a portfolio gap for most of the global players in the orthopedic and spine industry. The company is run by the management of SHS V portfolio company Blue Ocean Spine.

Summary

Salvia is developing neurostimulating devices which can be implanted under the skin to help those who suffer from chronic migraines. Salvia’s devices stimulate the nerves directly with high effectivity, at the same time having less issues of competing products as skin erosion, lead breakage etc. due to its usage of bioelectronics foils.

Summary

Selfapy is Germany’s leading provider of online therapy for mental health. Selfapy offers psychologically guided, anonymous, and flexible therapy programs to people suffering from psychological disorders. The three-month programs were developed together with experienced psychotherapists and are based on the principles of cognitive behavioural therapy. Covered indications include Depression, Anxiety Disorders, Burnout, Eating Disorders or Stress.

Summary

Rapid-growing company that offers unique super-high-pressure balloon catheters (up to 35 atm), used for treatment of cardiovascular stenotic lesions, even the rapidly increasing numbers of highly calcified ones.

Summary

Highly specialized devices, catheters and probes for neurosurgical use in the brain.

• Monitors and probes for intracranial pressure monitoring
• External ventricular drainage systems for drainage of liquor
• Shunt valves and catheters for hydrocephalus patients

Summary

Highly innovative dental implant system company – designed and manufactured in Switzerland. TRI® offers the best-in-class digital portfolio and is additionally developing a Digital-Implant which integrates the first-ever dental implant-connection specifically designed for CAD/CAM and 3D-printed prosthetics and thus allows for the connection of a ceramic crown directly to the implant, eliminating the need for an abutment.

Summary

Pioneer in digitizing rehabilitation. Tryomotion develops and distributes robot- and computer-assisted therapeutic devices for the rehabilitation sector worldwide. Their customer base is based on global blue chip rehab centers.